The Patent Finder

Glycominds, LLC

Also on record
Records under this name other than patents Glycominds, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Glycominds, LLC

PatentTitleStatus Expires Confidence
US 11,480,569Biomarker test and method for assessing mucosal healing in response to treatment of ulcerative colitis
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,608,414Method for diagnosing and prognosing inflammatory bowel disease and crohn's disease
Formerly held
Term ended
Ended no later than Feb 8, 2026 · From the USPTO record
Term endedEnded no later than Feb 8, 2026From the USPTO record
US 7,592,150Method for diagnosing diseases based on levels of anti-glycan antibodies
Formerly held
Term ended
Term ended Jan 18, 2025 · From the USPTO record
Term endedTerm ended Jan 18, 2025From the USPTO record
US 7,906,291Method for diagnosing multiple sclerosis
Lapsed on the fee record
Ended Mar 15, 2023 · From the USPTO record
Lapsed on the fee recordEnded Mar 15, 2023From the USPTO record
US 7,572,592Method for diagnosing multiple sclerosis
Lapsed on the fee record
Ended Aug 11, 2021 · From the USPTO record
Lapsed on the fee recordEnded Aug 11, 2021From the USPTO record
US 8,216,791Method for diagnosing multiple sclerosis
Lapsed on the fee record
Ended Jul 10, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jul 10, 2020From the USPTO record
US 8,129,128Immunoassay reagent compositions for diagnosing multiple sclerosis
Lapsed on the fee record
Ended Mar 6, 2020 · From the USPTO record
Lapsed on the fee recordEnded Mar 6, 2020From the USPTO record
US 6,972,172Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
Formerly held
Term ended
Term ended Feb 17, 2020 · From the USPTO record
Term endedTerm ended Feb 17, 2020From the USPTO record
US 6,994,966Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
Formerly held
Term ended
Term ended Feb 17, 2020 · From the USPTO record
Term endedTerm ended Feb 17, 2020From the USPTO record
US 8,048,639Method for evaluating risk in multiple sclerosis
Lapsed on the fee record
Ended Nov 1, 2019 · From the USPTO record
Lapsed on the fee recordEnded Nov 1, 2019From the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited